Prognostic Effect of Body Composition in Cancer Survivors
The Impact of DXA-Based Body Composition Phenotypes on the All-cause Mortality Among the US Cancer Survivors
1 other identifier
observational
1,500
0 countries
N/A
Brief Summary
This study aims to evaluate the association between body composition and mortality risk among the US population based on data from the National Health and Nutrition Examination Survey (NHANES), a nationally representative cohort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 1999
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedFirst Submitted
Initial submission to the registry
April 24, 2024
CompletedFirst Posted
Study publicly available on registry
May 3, 2024
CompletedMay 3, 2024
April 1, 2024
20 years
April 24, 2024
May 2, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Rate of all-cause mortality
To evaluate the association between fat mass index (FMI, fat mass and height will be combined to report FMI in kg/m\^2) and all-cause mortality among cancer survivors.
Jan 1 1999 to Dec 31 2019
Rate of all-cause mortality
To evaluate the association between muscle mass index (MMI, muscle mass and height will be combined to report MMI in kg/m\^2) and all-cause mortality among cancer survivors.
Jan 1 1999 to Dec 31 2019
Interventions
body composition of cancer survivors were assessed by Dual-energy X-ray absorptiometry
Eligibility Criteria
The data were extracted from National Health and Nutrition Examination Survey (NHANES) 1999 to 2006 and 2011 to 2018.
You may qualify if:
- Participants with cancer diagnosis beyond 18 years old.
You may not qualify if:
- Participants with missing cancer investigations and incomplete DXA body composition data were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 230 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
April 24, 2024
First Posted
May 3, 2024
Study Start
January 1, 1999
Primary Completion
December 31, 2018
Study Completion
December 31, 2018
Last Updated
May 3, 2024
Record last verified: 2024-04